EQS-News: APONTIS PHARMA AG / Key word(s): Change in Forecast/AllianceAPONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications and raises forecast 05.04.2024 / 10:17 CET/CESTThe issuer is solely responsible for the content of this announcement.APONTIS PHARMA enter.
EQS-News: APONTIS PHARMA AG / Key word: Change in Forecast/Alliance
APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications.
This retrospective cohort study evaluated baseline demographics, clinical characteristics, and treatment patterns of US patients with asthma who newly initiated single- or multiple-inhaler triple therapy.